La Jolla, CANCT06981234Now EnrollingIRB Ready

Type 1 Diabetes Clinical Trial in La Jolla, CA

Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.

Sponsored by University of California, San Diego

Quick Self-Assessment

See if you qualify for this La Jolla location

Preparing your pre-screening questions…

Expert Care in La Jolla

Access type 1 diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 1 diabetes treatment provided free

Apply for This La Jolla Location

Check if you qualify for this type 1 diabetes clinical trial in La Jolla, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to La Jolla

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit La Jolla site if eligible
  4. 4Begin participation

About This Type 1 Diabetes Study in La Jolla

The goal of this study is to learn about the effect of the study drug acetazolamide in individuals with Type 1 Diabetes. Specifically, whether acetazolamide provides benefits to the kidneys while minimizing any side effects of the drug. These changes will be measured by laboratory tests that tell us how well the kidneys are functioning.

Sponsor: University of California, San Diego

Who Can Participate

Inclusion Criteria

Males and Females ≥ 18 years at the time of consent.
Individuals able to become pregnant of non-child bearing potential must be ≥ 1 year post-menopausal or documented as being surgically sterile. Individuals of child bearing potential must agree to use two methods of contraception during the entire study.
Individuals able to cause a pregnancy must be willing to use clinically acceptable method of contraception during the entire study.
Have a clinical diagnosis of Type 1 Diabetes on a stable medication regimen for at least 3 months.
eGFR (estimated glomerular filtration rate) ≥ 45ml/min/1.73m2
Serum bicarbonate ≥ 24 meq/L
Negative urine toxicology screen.
Able to provide written informed consent approved by an Institutional Review Board (IRB).

Exclusion Criteria

History of allergic reaction to acetazolamide, another carbonic anhydrase inhibitor, or any of the inactive ingredients in the acetazolamide tablets.
Liver disease (clinical diagnosis of cirrhosis by imaging of physician; \> 14 drinks/week; AST (Aspartate Transferase), ALT (Alanine Aminotransferase), or total bilirubin \> 2 times the upper limit of normal).
Serum hemoglobin A1c \> 10.0%
Serum hemoglobin concentration of \<8 g/dL.
Use of \> 4 anti-hypertensives, or systolic blood pressure \>160mm Hg at the screening visit.
Use of loop, thiazide or potassium sparing diuretics.
A medical condition requiring active surgical or medical intervention whose urgency would preclude participation in this study at the discretion of the site investigator (active cardiac or pulmonary conditions, ongoing ischemia or cardiac symptoms, uncorrected Coronary Artery Disease (CAD) or decompensated congestive heart failure (CHF)).
Institutionalized individual (prisoners, patients with signification mental illness, or nursing home residents).
Active pregnancy, breastfeeding, or planning to become pregnant during the study period.
Current participation in another clinical trial (observational studies are exempted) trial.
In the opinion of the investigators, inability to adhere to the study medical regimen or comply with recommendations.
Inability or unwillingness to travel to study visits.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in La Jolla?

Yes, this clinical trial (NCT06981234) has an active research site in La Jolla, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 1 Diabetes Treatment Options in La Jolla, CA

If you're searching for type 1 diabetes treatment options in La Jolla, CA, this clinical trial (NCT06981234) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 1 diabetes clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in La Jolla, CA

See all pulmonary embolism clinical trials recruiting in La Jolla — not just this study.

Browse Pulmonary Embolism Trials in La Jolla

Ready to Join in La Jolla?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · La Jolla, CA